The FDA has expanded the label of Bayer’s kidney disease drug Kerendia to include treatment of patients with two types of heart failure.

Water is at the heart of the disruption wrought by climate change. The seas, once seen as vast and stable, are now ...

BAYRY wins FDA nod to expand Kerendia's label, making it the only approved non-steroidal MR antagonist for two major conditions.

There have been some interesting takes on Saturday’s protest in London by supporters of Palestine Action. The police arrested ...

There are mad inventions, such as weight-loss drugs or the contraceptive Pill, that come out of the blue and change the world ...

Researchers have found the first new type of magnet in nearly a century. Now, these strange "altermagnets" could help us ...

Far over the misty mountains cold,” Dad read. Every evening before my light was turned out, he read me a story about a hobbit ...

Bayer AG BAYRY announced that the FDA has approved a label expansion of kidney disease drug Kerendia (finerenone). The regulatory body approved finerenone for the treatment of adult patients with ...

AstraZeneca has been cleared to include cardiovascular and kidney outcomes data on the label of its type 2 diabetes therapy Forxiga in the EU which could help it challenge rival drugs in the SGLT2 ...

Boehringer and Eli Lilly have moved closer to a heart failure indication for their SGLT2 inhibitor Jardiance, as the FDA starts a fast-track review of the drug in its first use beyond diabetes ...

You don’t need to just take my word for it, as I had the great pleasure of talking with Cregger about it this week, and discussion of Stephen King’s influence on the new horror movie is the headlining ...